KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $558.7 million.

  • Encompass Health's Other Accumulated Expenses rose 1948.25% to $558.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $558.7 million, marking a year-over-year increase of 1948.25%. This contributed to the annual value of $505.1 million for FY2024, which is 16953.04% up from last year.
  • Encompass Health's Other Accumulated Expenses amounted to $558.7 million in Q3 2025, which was up 1948.25% from $525.9 million recorded in Q2 2025.
  • In the past 5 years, Encompass Health's Other Accumulated Expenses ranged from a high of $611.2 million in Q2 2022 and a low of $177.3 million during Q4 2021
  • Over the past 5 years, Encompass Health's median Other Accumulated Expenses value was $471.2 million (recorded in 2024), while the average stood at $443.8 million.
  • As far as peak fluctuations go, Encompass Health's Other Accumulated Expenses plummeted by 3190.45% in 2023, and later surged by 16953.04% in 2024.
  • Encompass Health's Other Accumulated Expenses (Quarter) stood at $177.3 million in 2021, then rose by 2.14% to $181.1 million in 2022, then rose by 3.48% to $187.4 million in 2023, then skyrocketed by 169.53% to $505.1 million in 2024, then grew by 10.61% to $558.7 million in 2025.
  • Its Other Accumulated Expenses stands at $558.7 million for Q3 2025, versus $525.9 million for Q2 2025 and $531.5 million for Q1 2025.